NEURON-SPECIFIC ENOLASE (CLIA) WIENER LAB
Mexico·Clase I·III. DIAGNOSTIC AGENTS·REPRESENTACIONES LABIN MÉXICO, S.A. DE C.V.·Registered July 30, 2019INMUNOENSAYO QUIMIOLUMINISCENTE (CLIA) PARA LA DETERMINACIÓN CUANTITATIVA DE ENOLASA NEUROESPECÍFICA (NSE) EN SUERO. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETE.
CHEMOLUMINESCENT IMMUNOASSAY (CLIA) FOR THE QUANTITATIVE DETERMINATION OF NEUROSPECIFIC ENOLASE (NSE) IN SERUM. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- INMUNOENSAYO PARA LA DETERMINACIÓN DE ENOLASA NEUROESPECÍFICA (NSE)
- Trade Name (English)
- IMMUNOASSAY FOR THE DETERMINATION OF NEUROSPECIFIC ENOLASE (NSE)
- Analysis ID
- 1496R2019 SSA
- Registration Date
- July 30, 2019
- Name (Spanish)
- REPRESENTACIONES LABIN MÉXICO, S.A. DE C.V.
- Name (English)
- REPRESENTACIONES LABIN MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for NEURON-SPECIFIC ENOLASE (CLIA) WIENER LAB (NEURON-SPECIFIC ENOLASE (CLIA) WIENER LAB) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1496R2019 SSA and manufactured by REPRESENTACIONES LABIN MÉXICO, S.A. DE C.V.. The device was registered on July 30, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.